Impact of angiotensin II pathway inhibition on tumor response to anti PD(L)1 based therapy. (October 2020) - Strauss, J.; Rajan, A.; Apolo, A.; Lee, J.M.; Thomas, A.; Chen, A.; Coyne, G. O'Sullivan; Madan, R.; Bilusic, M.; Karzai, F.; Sater, H. Abdul; Redman, J.; et al.